Why the study?
Do CHIP diuretics (chlorthalidone, indapamide, PSD/HCTZ) reduce left ventricular mass more than hydrochlorothiazide in hypertensive patients?
Do CHIP diuretics (chlorthalidone, indapamide, PSD/HCTZ) reduce left ventricular mass more than hydrochlorothiazide in hypertensive patients?
CHIP diuretics (chlorthalidone, indapamide, and potassium-sparing diuretics) reduce left ventricular mass approximately 2-fold more than hydrochlorothiazide in hypertensive patients, independent of blood pressure reduction.
No takes yet. Share an insight, caveat, or question.
May support preferring CHIP diuretics for LVM reduction in hypertension; extends evidence on thiazide-type diuretic selection.
Roush et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: